Evidence mapPaperPMID 41935406Full record

Observational studyThe journal of prevention of Alzheimer's disease2026

Dementia risk factor assessment in a local Alzheimer's prevention population: a German cross-sectional, observational study.

Lena Sannemann, Michelle Gerards, Lara Bohr, Frederic Brosseron, Claus Escher, Franziska Kalthegener, Theresa Müller, Alfredo Ramírez, Philip Zeyen, Frank Jessen and 1 more

Abstract readObservational Study
In one paragraph

Observational study in The journal of prevention of Alzheimer's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lena SannemannDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and Cologne University Hospital, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Michelle GerardsDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and Cologne University Hospital, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Lara BohrDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and Cologne University Hospital, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Frederic BrosseronGerman Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1/99 53127 Bonn, Germany.
Claus EscherGerman Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1/99 53127 Bonn, Germany; Department of Geriatric Psychiatry and Cognitive Disorders, University Hospital Bonn, Venusberg-Campus 1 53127 Bonn, Germany.
Franziska KalthegenerDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and Cologne University Hospital, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Theresa MüllerDepartment of Pediatrics, Faculty of Medicine and Cologne University Hospital, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Alfredo RamírezDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and Cologne University Hospital, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany; German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1/99 53127 Bonn, Germany; Department of Geriatric Psychiatry and Cognitive Disorders, University Hospital Bonn, Venusberg-Campus 1 53127 Bonn, Germany; Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Faculty of Medicine and Cologne University Hospital, University of Cologne, Joseph-Stelzmann-Straße 26 50931 Cologne, Germany.
Philip ZeyenDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and Cologne University Hospital, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Frank JessenDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and Cologne University Hospital, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany; German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1/99 53127 Bonn, Germany; Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Faculty of Medicine and Cologne University Hospital, University of Cologne, Joseph-Stelzmann-Straße 26 50931 Cologne, Germany. Electronic address: frank.jessen@uk-koeln.de.
Ayda RostamzadehDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and Cologne University Hospital, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany. Electronic address: ayda.rostamzadeh@uk-koeln.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe risk for dementia is to a significant extent driven by potentially modifiable factors. Prevention strategies are increasingly aiming at individually tailored risk reduction approaches, particularly in light of emerging Brain Health Services for dementia prevention (dBHS).

methodsThe cross-sectional observational study "Individual Risk Profiling for Alzheimer's and Dementia Prevention" (INSPIRATION) assessed the individual risk factors of 162 participants of the local Cologne Alzheimer Prevention Registry and provided individual feedback on risk profiles during a single visit. We analysed the frequency and patterns of risk factors and explored their association with cognition and Alzheimer's disease (AD) plasma biomarkers.

findingsThe most common risk factors in this population were obesity, non-adherence to a Mediterranean diet, low subjective sleep quality, subjective experience of stress, and hearing impairment. A principal component analysis (PCA) revealed six principal components (PC), which we labeled as (1) psychosocial factors, (2) blood pressure, (3) physical condition, (4) hearing impairment, (5) lifestyle, and (6) substance use. We found isolated associations between PCs, cognition, and AD plasma biomarkers.

interpretationThese findings provide initial insights into which risk factors may be most relevant and actionable for highly-educated and prevention-motivated populations likely to seek dBHS. Interventions addressing the domains of psychosocial factors, physical condition, and lifestyle may be particularly relevant to consider for a personally tailored risk reduction approach in comparable populations.

fundingThe study was funded by research funds of the Medical Faculty and the University Hospital Cologne, University of Cologne and the non-profit association Kölner Verein für seelische Gesundheit e.V.

Indexed as

Alzheimer DiseaseDementiaAgedBiomarkersCross-Sectional StudiesFemaleGermanyHumansMaleObesityRisk AssessmentRisk FactorsBiomarkersAlzheimer’s diseaseDementiaModifiable risk factorsPreventionRisk assessmentRisk communication

Identifiers

PMID41935406
PMCPMC13088994

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.